GILLIS STEVEN purchased 199.7% of their position (5M shares) of CODIAK BIOSCIENCES, INC. on the open market
Open‑market purchases signal personal conviction — classified as a major conviction buy.
P · 1 purchase
Filed: 9/15/2022ACC: 0001062993-22-019587
+10M
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
10M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+5M
Price / share
—
Trade value
—
% of position
199.7%
9/13/2022
2.50M→7.50M
Total
Net shares
+5M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/13/2022 | P · Purchase | +5M | — | — | 199.7% | 2.50M | 7.50M |
| Total | +5M | $0.00 | ||||||
Derivative Transactions1
Warrant (Right to Buy)
Indirect
Converts to
Common Stock
5M shares
Shares
+5M
Strike price
1.875
Held after
5M
Exercisable
—
9/13/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (Right to Buy) Indirect | Common Stock5M shares | 9/13/2022 | P · Purchase | +5M | 1.875 | — | 5M |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned10.25K
Total
10.25K direct10.25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.25K | Direct |
| Total | 10.25K | 10.25K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported